160 related articles for article (PubMed ID: 10673178)
41. Incidence of medico-surgical treatment for nasal polyps on the development of associated asthma.
Jankowski R; Moneret-Vautrin DA; Goetz R; Wayoff M
Rhinology; 1992 Dec; 30(4):249-58. PubMed ID: 1470826
[TBL] [Abstract][Full Text] [Related]
42. [Clinical significance of pulmonary function test in patients with chronic rhinosinusitis with nasal polyps].
Gu X; Ye P; Chen FY; Chen YL; Yang Y; Zhang LQ; Shi L
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2013 Mar; 48(3):244-7. PubMed ID: 23755793
[TBL] [Abstract][Full Text] [Related]
43. Corticosteroid treatment in nasal polyposis with a three-year follow-up period.
Bonfils P; Norès JM; Halimi P; Avan P
Laryngoscope; 2003 Apr; 113(4):683-7. PubMed ID: 12671429
[TBL] [Abstract][Full Text] [Related]
44. Improvement in bronchial hyperresponsiveness with inhaled corticosteroids in children with asthma: importance of family history of bronchial hyperresponsiveness.
Koh YY; Lee MH; Sun YH; Park Y; Kim CK
Am J Respir Crit Care Med; 2002 Aug; 166(3):340-5. PubMed ID: 12153967
[TBL] [Abstract][Full Text] [Related]
45. Effect of inhaled beclomethasone dipropionate on isocapnic hyperventilation with cold air in asthmatics, measured with forced oscillation technique.
Pennings HJ; Wouters EF
Eur Respir J; 1997 Mar; 10(3):665-71. PubMed ID: 9073002
[TBL] [Abstract][Full Text] [Related]
46. Involvement of IL-9 in the bronchial phenotype of patients with nasal polyposis.
Tsicopoulos A; Shimbara A; de Nadai P; Aldewachi O; Lamblin C; Lassalle P; Walls AF; Sénéchal S; Levitt RC; Darras J; Hamid Q; Wallaert B
J Allergy Clin Immunol; 2004 Mar; 113(3):462-9. PubMed ID: 15007348
[TBL] [Abstract][Full Text] [Related]
47. Pulmonary function parameters in patients with allergic rhinitis.
Bavbek S; Saryal S; Karabiyikoglu G; Misirligil Z
J Investig Allergol Clin Immunol; 2003; 13(4):252-8. PubMed ID: 14989114
[TBL] [Abstract][Full Text] [Related]
48. Different effects of nasal and bronchial glucocorticosteroid administration on bronchial hyperresponsiveness in patients with allergic rhinitis.
Aubier M; Levy J; Clerici C; Neukirch F; Herman D
Am Rev Respir Dis; 1992 Jul; 146(1):122-6. PubMed ID: 1626795
[TBL] [Abstract][Full Text] [Related]
49. Methacholine and adenosine 5'-monophosphate (AMP) responsiveness, and the presence and degree of atopy in children with asthma.
Suh DI; Lee JK; Kim CK; Koh YY
Pediatr Allergy Immunol; 2011 Feb; 22(1 Pt 2):e101-6. PubMed ID: 21342276
[TBL] [Abstract][Full Text] [Related]
50. Early intervention with inhaled corticosteroids in subjects with rapid decline in lung function and signs of bronchial hyperresponsiveness: results from the DIMCA programme.
den Otter JJ; van Schayck CP; Folgering HT; van den Boom G; Akkermans RP; van Weel C
Eur J Gen Pract; 2007; 13(2):89-91. PubMed ID: 17534745
[TBL] [Abstract][Full Text] [Related]
51. Does bronchial hyperresponsiveness in childhood predict active asthma in adolescence?
Riiser A; Hovland V; Carlsen KH; Mowinckel P; Lødrup Carlsen KC
Am J Respir Crit Care Med; 2012 Sep; 186(6):493-500. PubMed ID: 22798318
[TBL] [Abstract][Full Text] [Related]
52. Relationship of house-dust mite allergen exposure in children's bedrooms in infancy to bronchial hyperresponsiveness and asthma diagnosis by age 6 to 7.
Carter PM; Peterson EL; Ownby DR; Zoratti EM; Johnson CC
Ann Allergy Asthma Immunol; 2003 Jan; 90(1):41-4. PubMed ID: 12546336
[TBL] [Abstract][Full Text] [Related]
53. [Bronchial asthma--how important is the clarification of the allergy component?].
Stratakis DF
MMW Fortschr Med; 2006 Apr; 148(16):30-3; quiz 34. PubMed ID: 16688946
[TBL] [Abstract][Full Text] [Related]
54. Recurrent exacerbations in severe asthma are associated with enhanced airway closure during stable episodes.
in 't Veen JC; Beekman AJ; Bel EH; Sterk PJ
Am J Respir Crit Care Med; 2000 Jun; 161(6):1902-6. PubMed ID: 10852764
[TBL] [Abstract][Full Text] [Related]
55. Testing bronchial hyper-responsiveness: provocation or peak expiratory flow variability?
den Otter JJ; Reijnen GM; van den Bosch WJ; van Schayck CP; Molema J; van Weel C
Br J Gen Pract; 1997 Aug; 47(421):487-92. PubMed ID: 9302787
[TBL] [Abstract][Full Text] [Related]
56. Interacting effects of atopy and bronchial hyperresponsiveness on the annual decline in lung function and the exacerbation rate in asthma.
Van Schayck CP; Dompeling E; Van Herwaarden CL; Wever AM; Van Weel C
Am Rev Respir Dis; 1991 Dec; 144(6):1297-301. PubMed ID: 1741542
[TBL] [Abstract][Full Text] [Related]
57. The prevalence of asthma symptoms, bronchial hyperresponsiveness and atopy in New Zealand adults.
D'Souza W; Lewis S; Cheng S; McMillan D; Pearce N; Town I; Rigby S; Skidmore C; Armstrong R; Rutherford R
N Z Med J; 1999 Jun; 112(1089):198-202. PubMed ID: 10414619
[TBL] [Abstract][Full Text] [Related]
58. Persistent asthma after repeated exposure to high concentrations of gases in pulpmills.
Chang-Yeung M; Lam S; Kennedy SM; Frew AJ
Am J Respir Crit Care Med; 1994 Jun; 149(6):1676-80. PubMed ID: 8004329
[TBL] [Abstract][Full Text] [Related]
59. Increased frequency of asymptomatic bronchial hyperresponsiveness in nonasthmatic patients with food allergy.
Thaminy A; Lamblin C; Perez T; Bergoin C; Tonnel AB; Wallaert B
Eur Respir J; 2000 Dec; 16(6):1091-4. PubMed ID: 11292111
[TBL] [Abstract][Full Text] [Related]
60. Dissociation of symptom scores and bronchial hyperreactivity: study in asthmatic children on long-term treatment with inhaled beclomethasone dipropionate.
Benoist MR; Brouard JJ; Rufin P; Waernessyckle S; de Blic J; Paupe J; Scheinmann P
Pediatr Pulmonol; 1992 Jun; 13(2):71-7. PubMed ID: 1495860
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
